Eric Cantor appointed CEO of PhRMA lobbying group
Former House majority leader Eric Cantor will lead PhRMA starting Tuesday in Washington.
Cantor takes top role at industry group
The lobbying group announced the appointment on Tuesday. Eric Cantor previously served as GOP House majority leader before this new position.
Political pressure mounts on drug pricing
Cantor will face increasing political pressure regarding drug prices from both major parties. The Trump administration seeks to codify voluntary agreements with dozens of companies to lower U.S. pharmaceutical prices.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.